Caliway Biopharmaceuticals Co. L (6919.TW) Earnings Analysis
Caliway Biopharmaceuticals Co. L (6919.TW) next reports earnings on 2026-08-07, consensus EPS 2.91 TWD. Last quarter (2025-11-07) it beat with EPS -0.00016 TWD vs -0.00623 TWD est (+97.4%). It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E -554.33.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6919.TW next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | 2.91 TWD |
| Revenue estimate | 6.01B |
6919.TW earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-11-07 | -0.00016 TWD | -0.00623 TWD | +97.4% | Beat |
Beat rate: 1/1 (100%) over reported quarters with consensus data.
6919.TW valuation and analyst view
| Trailing P/E | -554.33 |
|---|---|
| Trailing EPS | -0.1826 TWD |
| Price / book | 16.63 |
| Dividend yield | 0.00% |
| Market cap | 161.86B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Caliway Biopharmaceuticals Co. L (6919.TW)'s next earnings date?
Caliway Biopharmaceuticals Co. L is next scheduled to report on 2026-08-07, with a consensus EPS estimate of 2.91 TWD and revenue estimate of 6.01B.
Did 6919.TW beat earnings last quarter?
In its 2025-11-07 report, 6919.TW posted EPS of -0.00016 TWD versus a -0.00623 TWD estimate — a beat of 97.4%.
What is 6919.TW's earnings track record?
Over the last 1 reported quarters with consensus data, 6919.TW beat estimates 1 times (100%).
What is 6919.TW's current P/E ratio and EPS?
6919.TW trades at a trailing P/E of -554.33 on trailing EPS of -0.18259841193422846 TWD.
What do analysts rate 6919.TW?
6919.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.